Financials
Financial year 2025
Orifarm Healthcare from Zaventem, company number BE0755731948, closed financial year 2025 with a result of € 197,513 after tax. For that financial year Orifarm Healthcare recorded revenue of € 31.3 million and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 327,032 to € 197,513. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
€ 1.7 million
▲ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 197,513
▼ 40% vs 2024
Profit after tax over the fiscal year.
€ 465,209
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.7 million.
People and assets in 2025
21.5
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 3.5 million
▲ 2% vs 2024
€ 164,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2.5 million
▲ 54% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 33 days on average.
€ 831,732
▼ 21% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | € 29,276,633 | € 31,311,569 | ▲ 7% |
| Gross margin | € 3,770,930 | € 4,293,402 | - | - | |
| Profit after taxes | € 319,984 | € 353,106 | € 327,032 | € 197,513 | ▼ 40% |
| Equity | € 815,543 | € 1,168,648 | € 1,495,681 | € 1,693,194 | ▲ 13% |
| Total debts | € 6,463,513 | € 7,283,663 | € 6,803,548 | € 4,743,165 | ▼ 30% |
| Cash | - | - | - | € 465,209 | |
| Retained profit | € 805,543 | € 1,158,648 | € 1,485,681 | € 1,683,194 | ▲ 13% |
| Bank debt | € 237,880 | € 2,109,196 | € 3,276,414 | € 0 | ▼ 100% |
| Balance sheet total | € 7,279,055 | € 8,452,311 | € 8,299,229 | € 6,496,360 | ▼ 22% |
| Employees (FTE) | 19.5 | 21.7 | 21.4 | 21.5 | ▲ 0.1 |
Key figures of Orifarm Healthcare, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Orifarm Healthcare?
What happened at Orifarm Healthcare in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 197,513 (▼ 40% vs 2024). Source: NBB ↗
- Nicki Lund Kristensen became a director. NBB
- Mads Fink Eriksen became a director. NBB
- Thomas Brandhof became a director. NBB
- New establishment in Zaventem. KBO
- Hans Carl Boegh-Soerensen became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 319,984 profit in 2022 to € 197,513 profit in 2025.
Paid € 581,628 in corporate taxes since 2022.
Best year ever: 2023, with € 353,106 profit.
On average € 197,900 of value added per employee in 2023.
Management
Behind Orifarm Healthcare are Thomas Brandhof, Nicki Lund Kristensen, Mads Fink Eriksen and Hans Carl Boegh-Soerensen. The shares are held by Orifarm Generics A/S B.O (100%).
Directors
According to the 2025 annual accounts
since 2024
since 2025
since 2025
since 2020
Shareholders
Orifarm Generics A/S B.O
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Da Vincilaan 7
1930 Zaventem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →IQVIA Solutions Belgium
€ 33.1 million revenue · 2025
TAKEDA BELGIUM
€ 207.4 million revenue · 2026
IQVIA RDS & INTEGRATED SERVICES BELGIUM
€ 45.6 million revenue · 2025
IM ASSOCIATES
€ 3.1 million gross margin · 2025
IQVIA Cancer Research
€ 50,247 gross margin · 2025
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0755.731.948
- VAT number
- BE 0755.731.948
- Registered office
- Da Vincilaan 7, 1930 Zaventem
- Names & denominations
- Orifarm Healthcare
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 October 2020
- Peppol
- Active · Active since 11 Jun 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen